Erectile Dysfunction
📧 Sign up to get email alerts when something new happens for Erectile Dysfunction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-29FDA Approved: SILDENAFIL CITRATE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for sildenafil citrate tablets from Zydus Lifesciences Limited, enabling a generic version of sildenafil citr…
-
FDA approval · 2022-08-11FDA Approved: TADALAFIL — Original Application (Solco Healthcare US, LLC)
FDA approved an original ANDA for tadalafil tablets (generic tadalafil) by Solco Healthcare US, LLC. The product is approved for erectile dy…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction [Phase 1, Phase 2]
Clinical trial update for DualStim Therapy with or without Wharton's Jelly in erectile dysfunction across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED [Phase 2, Phase 3]
A clinical trial update on intracavernous injection of Botox 100 U for erectile dysfunction in patients inconvi... use of PDE5 inhibitors; P…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction [Phase 4]
Phase 4 clinical trial examining serum YKL-40 levels and platelet indices in patients with diabetic erectile dysfunction, completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2022-07-04EMA Authorised: Sildenafil Teva (sildenafil) — Teva B.V.
Authorised erectile dysfunction medicine sildenafil Teva (sildenafil) by Teva B.V. has received approval in the EU.
-
EMA approval · 2022-06-24EMA Authorised: Sildenafil ratiopharm (sildenafil) — Ratiopharm GmbH
EU authorization for Sildenafil ratiopharm for erectile dysfunction; marketing authorization granted to Ratiopharm GmbH.
-
FDA approval · 2022-06-17FDA Approved: TADLIQ — Original Application (CMP Pharma, Inc.)
FDA approved CMP Pharma's TadliQ (tadalafil) under Original Application NDA214522, approving its use for erectile dysfunction and benign pro…
-
FDA approval · 2022-05-27FDA Approved: TADALAFIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Tadalafil submitted by Aurobindo Pharma Limited. This action adds regulatory approval for th…
-
FDA approval · 2022-05-18FDA Approved: TADALAFIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for tadalafil from Quallent Pharmaceuticals Health LLC. This action concerns the approval of a g…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: The Safety of Dapoxetine/Tadalafil Combination Therapy [Phase 4]
Phase 4 clinical trial update evaluating the safety of a dapoxetine/tadalafil combination therapy for premature ejaculation and erectile dys…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment [Phase 2, Phase 3]
Phase 2/3 clinical trial update comparing LiST Plus PRP Injection Therapy to LiST Monotherapy for erectile dysfunction.
-
FDA approval · 2022-04-29FDA Approved: SILDENAFIL CITRATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for sildenafil citrate submitted by Ascend Laboratories, LLC, resulting in approval of a generic…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating intracavernosal umbilical cord mesenchymal stem cell implantation for erectile dysfunction in diabetes; …
-
FDA approval · 2022-03-23FDA Approved: SILDENAFIL — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' original application for sildenafil, a generic version of the erectile dysfunction treatment.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction [Phase 3]
Phase 3 clinical trial using topically applied glyceryl trinitrate (GTN) for erectile dysfunction completed.
-
EMA withdrawal · 2022-02-28EMA Withdrawn: Vivanza (vardenafil) — Bayer AG
EMA has withdrawn Vivanza (vardenafil) from the market (Bayer AG) for erectile dysfunction.
-
FDA approval · 2022-02-08FDA Approved: SILDENAFIL CITRATE — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved Sildenafil Citrate (generic) from Novadoz Pharmaceuticals LLC under an Original Application (ANDA), enabling market entry f…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy [NA]
Clinical trial update on pharmacological penile rehabilitation following bilateral nerve-sparing radical prostatectomy; study terminated wit…
-
FDA approval · 2021-11-04FDA Approved: TADALAFIL — Original Application (Burel Pharmaceuticals, LLC)
The FDA approved a generic tadalafil product under an original ANDA for Burel Pharmaceuticals, LLC.
-
EMA withdrawal · 2021-10-05EMA Application withdrawn: Sildenafil FGK (sildenafil citrate) — FGK Representative Service GmbH
A regulatory application for sildenafil citrate (Sildenafil FGK) has been withdrawn by FGK Representative Service GmbH for erectile dysfunct…
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction [Phase 2]
Phase II repeat-dose study in healthy male subjects with erectile dysfunction is ongoing; results not yet reported.
-
FDA approval · 2021-05-11FDA Approved: SILDENAFIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for a sildenafil powder product, a generic version of sildenafil.
-
FDA approval · 2021-04-29FDA Approved: SILDENAFIL — Original Application (Virtus Pharmaceuticals, LLC)
The FDA approved Virtus Pharmaceuticals' original ANDA for sildenafil, enabling a generic version of the erectile dysfunction drug.
-
FDA approval · 2021-03-17FDA Approved: TADALAFIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for tadalafil from Cipla USA Inc. under ANDA210255, expanding the approved generic product for a…